Evaluation of a structured report of functional prostate magnetic resonance imaging in patients with suspicion for prostate cancer or under active surveillance

Urologia Internationalis

Volumn 89, Issue 1, 2012, Pages 25-29

  Quentin, M ^a   Blondin, D ^a   Klasen, J ^a   Schek, J ^a   Buchbender, C ^a   Miese, F R ^a   Antoch, G ^a   Barski, D ^a   Albers, P ^a   Arsov, C ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Active surveillance; Magnetic resonance imaging; Prostate; Prostate cancer; Structured report

Indexed keywords

GADOTERATE MEGLUMINE;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE SURGERY; TRANSRECTAL ULTRASONOGRAPHY;

ADULT; AGED; BIOPSY; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; DOCUMENTATION; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FORMS AND RECORDS CONTROL; GERMANY; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; UP-REGULATION; WATCHFUL WAITING;

EID: 84864608826     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000338808     Document Type: Article

References (20)

1. Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Mottet N, Schmid HP, van der Kwast T, Wiegel T, Zattoni F: EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and treatment of clinically loca lised disease. Eur Urol 2011; 59: 61-71.
2. Aigner F, Pallwein L, Junker D, Schäfer G, Mikuz G, Pedross F, Mitterberger MJ, Jaschke W, Halpern EJ, Frauscher F: Value of real-time elastography targeted biopsy for prostate cancer detection in men with prostate-specific antigen 1.25 ng/ml or greater a nd 4.00 ng/ml or less. J Urol 2010; 184: 913-917.
3. Porten SP, Whitson JM, Cowan JE, Cooper-berg MR, Shinohara K, Perez N, Greene KL, Meng MV, Carroll PR: Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance. J Clin Oncol 2011; 29:2795-2800.
4. Yuen JS, Thng CH, Tan PH, Khin LW, Phee SJ, Xiao D, Lau WK, Ng WS, Cheng CW: En-dorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. J Urol 2004; 171:1482-1486. (Pubitemid 38365401)
5. Scattoni V, Zlotta A, Montironi R, Schulman C, Rigatti P, Montorsi F: Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: A critical analysis of the literature. Eur Urol 2007; 52: 1309-1322. (Pubitemid 47446019)
6. Djavan B, Ravery V, Zlotta A, Dobronski P, Dobrovits M, Fakhari M, Seitz C, Susani M, Borkowski A, Boccon-Gibod L, Schulman CC, Marberger M: Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? J Urol 2001; 166: 1679-1683.
7. Roehl KA, Antenor JA, Catalona WJ: Serial biopsy results in prostate cancer screening study. J Urol 2002; 167: 2435-2439. (Pubitemid 34533140)
8. Stewart CS, Leibovich BC, Weaver AL, Lieber MM: Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001; 166:86-91. (Pubitemid 32565349)
9. Merrick GS, Gutman S, Andreini H, Taubenslag W, Lindert DL, Curtis R, Ada-movich E, Anderson R, Allen Z, Butler W, Wallner K: Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy. Eur Urol 2007; 52:715-723.
10. Klotz LH: Active surveillance with selective delayed intervention: walking the line between overtreatment for indolent disease and undertreatment for aggressive disease. Can J Urol 2005; 12(suppl 1):53-57, 101-102.
11. Tabatabaei S, Saylor PJ, Coen J, Dahl DM: Prostate cancer imaging: what surgeons, radiation oncologists, and medical oncologists want to know. AJR Am J Roentgenol 2011; 196: 1263-1266.
12. Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Futterer JJ, Heijmink SW, Hoskin PJ, Kirkham A, Padhani AR, Persad R, Puech P, Punwani S, Sohaib AS, Tombal B, Villers A, van der Meulen J, Emberton M: Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol 2011; 59: 477-494.
13. Labanaris AP, Engelhard K, Zugor V, Nützel R, Kühn R: Prostate cancer detection using an extended prostate biopsy schema in combination with additional targeted cores from suspicious images in conventional and functional endorectal magnetic resonance imaging of the prostate. Prostate Cancer Prostatic Dis 2010; 13: 65-70.
14. Abdollah F, Novara G, Briganti A, Scattoni V, Raber M, Roscigno M, Suardi N, Gallina A, Artibani W, Ficarra V, Cestari A, Guaz-zoni G, Rigatti P, Montorsi F: Trans-rectal versus trans-perineal saturation rebiopsy of the prostate: is there a difference in cancer detection rate? Urology 2011; 77:921-925.
15. Prando A, Kurhanewicz J, Borges AP, Olivei-ra EM, Figueiredo E: Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate-specific antigen levels and prior negative biopsy findings: early experience. Radiology 2005; 236:903-910. (Pubitemid 41170854)
16. Singh AK, Kruecker J, Xu S, Glossop N, Guion P, Ullman K, Choyke PL, Wood BJ: Initial clinical experience with real-time transrectal ultrasonography- magnetic resonance imaging fusion-guided prostate biopsy. BJU Int 2008; 101:841-845. (Pubitemid 351347719)
17. Hambrock T, Fütterer JJ, Huisman HJ, Huls-bergen-vandeKaa C, van Basten JP, van Oort I, Witjes JA, Barentsz JO: Thirty-two-channel coil 3-T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3-T magnetic resonance imaging: technique and feasibility. Invest Radiol 2008; 43:686-694.
18. Hambrock T, Somford DM, Hoeks C, Bou-wense SA, Huisman H, Yakar D, van Oort IM, Witjes JA, Fütterer JJ, Barentsz JO: Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate-specific antigen. J Urol 2010; 183: 520-527.
19. Roethke M, Anastasiadis AG, Lichy M, Werner M, Wagner P, Kruck S, Claussen CD, Stenzl A, Schlemmer HP, Schilling D: MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy. World J Urol 2012; 30:213-218.
20. Xu H, Lasso A, Vikal S, Guion P, Krieger A, Kaushal A, Whitcomb LL, Fichtinger G: MRI-guided robotic prostate biopsy: a clinical accuracy validation. Med Image Comput Comput Assist Interv 2010; 13: 383-391.